Literature DB >> 12034691

Clinical and ocular motor analysis of the infantile nystagmus syndrome in the first 6 months of life.

R W Hertle1, V K Maldanado, M Maybodi, D Yang.   

Abstract

BACKGROUND/AIMS: The infantile nystagmus syndrome (INS) usually begins in infancy and may or may not be associated with visual sensory system abnormalities. Little is known about its specific waveforms in the first 6 months of life or their relation to the developing visual system. This study identifies the clinical and ocular motility characteristics of the INS and establishes the range of waveforms present in the first 6 months of life.
METHODS: 27 infants with involuntary ocular oscillations typical of INS are included in this analysis. They were evaluated both clinically and with motility recordings. Eye movement analysis was performed off line from computer analysis of digitised data. Variables analysed included age, sex, vision, ocular abnormalities, head position, and null zone, neutral zone characteristics, symmetry, conjugacy, waveforms, frequencies, and foveation times.
RESULTS: Ages ranged from 3 to 6.5 months (average 4.9 months). 15 patients (56%) had abnormal vision for age, nine (33%) had strabismus, five (19%) had an anomalous head posture, 13 (48%) had oculographic null and neutral positions, nine (33%) had binocular asymmetry, and only two showed consistent dysconjugacy. Average binocular frequency was 3.3 Hz, monocular frequency 6.6 Hz. Average foveation periods were longer and more "jerk" wave forms were observed in those patients with normal vision.
CONCLUSIONS: Common clinical characteristics and eye movement waveforms of INS begin in the first few months of infancy and waveform analysis at this time may help with both diagnosis and visual status.

Entities:  

Mesh:

Year:  2002        PMID: 12034691      PMCID: PMC1771154          DOI: 10.1136/bjo.86.6.670

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  40 in total

1.  Clinical and ocular motor analysis of congenital nystagmus in infancy.

Authors:  R W Hertle; L F Dell'Osso
Journal:  J AAPOS       Date:  1999-04       Impact factor: 1.220

2.  Visually impaired children with sensory defect nystagmus, normal appearing fundi and normal ERGS.

Authors:  J E Jan; W V Good; C J Lyons; R W Hertle
Journal:  Dev Med Child Neurol       Date:  1996-01       Impact factor: 5.449

3.  Congenital nystagmus.

Authors:  D G Cogan
Journal:  Can J Ophthalmol       Date:  1967-01       Impact factor: 1.882

4.  Vision development in the monocular individual: implications for the mechanisms of normal binocular vision development and the treatment of infantile esotropia.

Authors:  S Day
Journal:  Trans Am Ophthalmol Soc       Date:  1995

5.  Congenital nystagmus waveforms and foveation strategy.

Authors:  L F Dell'Osso; R B Daroff
Journal:  Doc Ophthalmol       Date:  1975-11-21       Impact factor: 2.379

6.  Electroretinography in congenital idiopathic nystagmus.

Authors:  G W Cibis; K M Fitzgerald
Journal:  Pediatr Neurol       Date:  1993 Sep-Oct       Impact factor: 3.372

7.  Effects of acupuncture on foveation characteristics in congenital nystagmus.

Authors:  T Blekher; T Yamada; R D Yee; L A Abel
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

8.  The effects of afferent stimulation on congenital nystagmus foveation periods.

Authors:  N V Sheth; L F Dell'Osso; R J Leigh; C L Van Doren; H P Peckham
Journal:  Vision Res       Date:  1995-08       Impact factor: 1.886

Review 9.  Clinical features and pathogenesis of acquired forms of nystagmus.

Authors:  R J Leigh
Journal:  Baillieres Clin Neurol       Date:  1992-08
View more
  12 in total

Review 1.  The clinical evaluation of infantile nystagmus: What to do first and why.

Authors:  Morgan Bertsch; Michael Floyd; Taylor Kehoe; Wanda Pfeifer; Arlene V Drack
Journal:  Ophthalmic Genet       Date:  2017 Jan-Feb       Impact factor: 1.803

2.  Beat-to-beat control of human optokinetic nystagmus slow phase durations.

Authors:  Carey D Balaban; Joseph M Furman
Journal:  J Neurophysiol       Date:  2016-10-19       Impact factor: 2.714

3.  Investigation of the gene mutations in two Chinese families with X-linked infantile nystagmus.

Authors:  Ningdong Li; Xiaojuan Wang; Yuchuan Wang; Liming Wang; Ming Ying; Ruifang Han; Yuyan Liu; Kanxing Zhao
Journal:  Mol Vis       Date:  2011-02-11       Impact factor: 2.367

4.  Eye muscle surgery for infantile nystagmus syndrome in the first two years of life.

Authors:  Richard W Hertle; Joost Felius; Dongsheng Yang; Matthew Kaufman
Journal:  Clin Ophthalmol       Date:  2009-11-16

5.  Using the NAFX to measure the effectiveness over time of gene therapy in canine LCA.

Authors:  Jonathan B Jacobs; Louis F Dell'Osso; Zhong I Wang; Gregory M Acland; Jean Bennett
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-20       Impact factor: 4.799

6.  Reliability and Validity of Gaze-Dependent Functional Vision Space: A Novel Metric Quantifying Visual Function in Infantile Nystagmus Syndrome.

Authors:  Tawna L Roberts; Kristi N Kester; Richard W Hertle
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-04-01       Impact factor: 4.799

7.  The role of MR imaging in investigating isolated pediatric nystagmus.

Authors:  Vaishnavi Batmanabane; Elise Heon; Tianyang Dai; Prakash Muthusami; Shiyi Chen; Arun Reginald; Shilpa Radhakrishnan; Manohar Shroff
Journal:  Pediatr Radiol       Date:  2016-08-12

8.  A novel splicing mutation of the FRMD7 gene in a Chinese family with X-linked congenital nystagmus.

Authors:  Ying Hu; Jing Shen; Shuihua Zhang; Tao Yang; Shangzhi Huang; Huiping Yuan
Journal:  Mol Vis       Date:  2012-01-13       Impact factor: 2.367

9.  Albinism: particular attention to the ocular motor system.

Authors:  Richard W Hertle
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jul-Sep

Review 10.  Abnormal head position in infantile nystagmus syndrome.

Authors:  Susana Noval; Mar González-Manrique; José María Rodríguez-Del Valle; José María Rodríguez-Sánchez
Journal:  ISRN Ophthalmol       Date:  2012-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.